초록 ▼

A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is

A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is sibutramine.

대표청구항 ▼

1. A method for treatment of symptoms of dystonia comprising administering a pharmaceutically effective amount of sibutramine, sibutramine salts or derivatives of sibutramine which is a selective reuptake inhibitor for dopamine, serotonin and norepinephrine thereof to a human in need of such treatme

1. A method for treatment of symptoms of dystonia comprising administering a pharmaceutically effective amount of sibutramine, sibutramine salts or derivatives of sibutramine which is a selective reuptake inhibitor for dopamine, serotonin and norepinephrine thereof to a human in need of such treatment. 2. A method for treatment of claim 1 wherein the pharmaceutically effective amount comprises about 0.25 mg to about 45 mg per day. 3. A method for treatment of claim 1 further comprising delivering said pharmaceutically acceptable amount in a controlled or sustained release form.